Zaragoza O - Search Results

1

Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.

Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. Zaragoza O, et al. Cell Microbiol. 2008 Oct;10(10):2043-57. doi: 10.1111/j.1462-5822.2008.01186.x. Epub 2008 Jun 28. Cell Microbiol. 2008. PMID: 18554313 Free PMC article.

2

Erratum for Velasco-de Andrés et al., "The Lymphocytic Scavenger Receptor CD5 Shows Therapeutic Potential in Mouse Models of Fungal Infection".

Velasco-de Andrés M, Català C, Casadó-Llombart S, Martínez-Florensa M, Simões I, García-Luna J, Mourglia-Ettlin G, Zaragoza Ó, Carreras E, Lozano F. Velasco-de Andrés M, et al. Among authors: zaragoza o. Antimicrob Agents Chemother. 2023 Dec 14;67(12):e0125323. doi: 10.1128/aac.01253-23. Epub 2023 Nov 16. Antimicrob Agents Chemother. 2023. PMID: 37971238 Free PMC article. No abstract available.

3

More is not necessarily better: prozone-like effects in passive immunization with IgG.

Taborda CP, Rivera J, Zaragoza O, Casadevall A. Taborda CP, et al. Among authors: zaragoza o. J Immunol. 2003 Apr 1;170(7):3621-30. doi: 10.4049/jimmunol.170.7.3621. J Immunol. 2003. PMID: 12646626

4

The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.

Zaragoza O, Taborda CP, Casadevall A. Zaragoza O, et al. Eur J Immunol. 2003 Jul;33(7):1957-67. doi: 10.1002/eji.200323848. Eur J Immunol. 2003. PMID: 12884862 Free article.

5

Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).

Zaragoza O, Fries BC, Casadevall A. Zaragoza O, et al. Infect Immun. 2003 Nov;71(11):6155-64. doi: 10.1128/IAI.71.11.6155-6164.2003. Infect Immun. 2003. PMID: 14573631 Free PMC article.

6

Experimental modulation of capsule size in Cryptococcus neoformans.

Zaragoza O, Casadevall A. Zaragoza O, et al. Biol Proced Online. 2004;6:10-15. doi: 10.1251/bpo68. Epub 2004 Mar 3. Biol Proced Online. 2004. PMID: 15103395 Free PMC article.

7

Effects of voriconazole on Cryptococcus neoformans.

van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. van Duin D, et al. Among authors: zaragoza o. Antimicrob Agents Chemother. 2004 Jun;48(6):2014-20. doi: 10.1128/AAC.48.6.2014-2020.2004. Antimicrob Agents Chemother. 2004. PMID: 15155193 Free PMC article.

8

Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

McFadden DC, Zaragoza O, Casadevall A. McFadden DC, et al. Among authors: zaragoza o. J Clin Microbiol. 2004 Jun;42(6):2786-8. doi: 10.1128/JCM.42.6.2786-2788.2004. J Clin Microbiol. 2004. PMID: 15184471 Free PMC article.

9

Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies.

Zaragoza O, Casadevall A. Zaragoza O, et al. Infect Immun. 2004 Jul;72(7):4271-4. doi: 10.1128/IAI.72.7.4271-4274.2004. Infect Immun. 2004. PMID: 15213172 Free PMC article.

10

Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.

Rivera J, Zaragoza O, Casadevall A. Rivera J, et al. Among authors: zaragoza o. Infect Immun. 2005 Feb;73(2):1141-50. doi: 10.1128/IAI.73.2.1141-1150.2005. Infect Immun. 2005. PMID: 15664957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page